Use of Risk Assessment Tools to Guide Decision-Making in the Primary Prevention of Atherosclerotic Cardiovascular Disease

Lloyd-Jones, Donald M., Braun, Lynne T., Ndumele, Chiadi E., Smith, Sidney C., Sperling, Laurence S., Virani, Salim S., Blumenthal, Roger S.·2019·Journal of the American College of Cardiology
DOI 10.1016/j.jacc.2018.11.005

Cited by (301)

Items 101–200 of 301

  1. Risk stratification for cardiovascular disease: a comparative analysis of cluster analysis and traditional prediction models
    Diego Yacamán-Méndez, Minhao Zhou, Boel Brynedal, Hrafnhildur Guðjónsdóttir, Per Tynelius, Ylva Trolle Lagerros, Anton Lager · 2025 · European Journal of Preventive Cardiology
  2. HOPE for Rational Statin Allocation for Primary Prevention: A Coronary Artery Calcium Picture Is Worth 1000 Words
    Carl E. Orringer, Kevin Carl Maki · 2020 · Mayo Clinic Proceedings
  3. A dynamic risk-based early warning monitoring system for population-based management of cardiovascular disease
    Xiaofei Liu, Qianqian Li, Weiye Chen, Peng Shen, Yexiang Sun, Qi Chen, Jinguo Wu, Jingyi Zhang, Ping Lu, Hongbo Lin et al. · 2021 · Fundamental Research
  4. A Framework for Considering the Value of Race and Ethnicity in Estimating Disease Risk
    Madison Coots, Soroush Saghafian, David M. Kent, Sharad Goel · 2024 · Annals of Internal Medicine
  5. Usefulness of Aspirin for Primary Prevention of Atherosclerotic Cardiovascular Disease
    Aneesha Thobani, Devinder Singh Dhindsa, Benjamin DeMoss, Mohamad Raad, Pratik B. Sandesara, Laurence S. Sperling, Jefferson Baer · 2019 · The American Journal of Cardiology
  6. The Journal of Cardiopulmonary Rehabilitation and Prevention at 40 yr and Its Role in Promoting Preventive Cardiology: Part 2
    Barry A. Franklin, Peter H. Brubaker, Matthew P. Harber, Carl J. Lavie, JONATHAN N. MYERS, Leonard A. Kaminsky · 2020 · Journal of Cardiopulmonary Rehabilitation and Prevention
  7. Performance of the American Heart Association/American College of Cardiology Pooled Cohort Equations to Estimate Atherosclerotic Cardiovascular Disease Risk by Self-reported Physical Activity Levels
    Ambarish Pandey, Anurag Mehta, Amanda E. Paluch, Hongyan Ning, Mercedes R. Carnethon, Norrina B. Allen, Erin D. Michos, Jarett D. Berry, Donald M. Lloyd‐Jones, John T. Wilkins · 2021 · JAMA Cardiology
  8. Characteristics of Transgender Women Referred to Women's Heart Clinic
    Madeline K. Mahowald, Arvind Maheshwari, Kyla M. Lara-Breitinger, Fadi Adel, Patricia A. Pellikka, Caroline Jane Davidge-Pitts, Todd B. Nippoldt, Birgit Kantor, Rekha Mankad · 2021 · American Journal of Preventive Cardiology
  9. Myocardial perfusion imaging for diabetes: Key points from the evidence and clinical questions to be answered
    Wanda Acampa, Roberta Assante, Emilia Zampella, Mario Petretta, Alberto Cuocolo · 2019 · Journal of Nuclear Cardiology
  10. Coronary artery calcium scoring in patients with hypertension
    Richard Lawrence Weinberg, Melvyn Rubenfire, Robert D. Brook · 2020 · Journal of Human Hypertension
  11. Machine learning reveals sex-specific associations between cardiovascular risk factors and incident atherosclerotic cardiovascular disease
    Soongu Kwak, Hyun‐Jung Lee, Seung Yeon Kim, Jun‐Bean Park, Seung‐Pyo Lee, Hyung‐Kwan Kim, Yong-Jin Kim · 2023 · Scientific Reports
  12. A Systematic Review on the Correlations between Left Atrial Strain and Cardiovascular Outcomes in Chronic Kidney Disease Patients
    Ana Tanasa, Alexandru Burlacu, Cristina Adriana Popa, Mehmet Kanbay, Crischentian Brinza, Liviu Macovei, Radu Adrian Crișan-Dabija, Adrian Constantin Covic · 2021 · Diagnostics
  13. Sex-specific added value of cardiac biomarkers for 10-year cardiovascular risk prediction
    Fang Zhu, Banafsheh Arshi, Maarten J.G. Leening, Elif Aribas, M. Arfan Ikram, Eric H. Boersma, M. Kamran Ikram, Maryam Kavousi · 2022 · European Journal of Preventive Cardiology
  14. Elevated apolipoprotein B as a risk-enhancing factor in 2018 cholesterol guidelines
    Scott M. Grundy, Neil J. Stone · 2019 · Journal of clinical lipidology
  15. Automated Deep Learning-Based Detection of Early Atherosclerotic Plaques in Carotid Ultrasound Imaging
    Murad Omarov, Lanyue Zhang, Saman Doroodgar Jorshery, Rainer Malik, Barnali Das, Tiffany R. Bellomo, Ulrich Mansmann, Martin J. Menten, Pradeep Natarajan, Martin Dichgans et al. · 2024 · medRxiv
  16. Predicted cardiovascular risk for United States adults with diabetes, chronic kidney disease, and at least 65 years of age
    Byron C. Jaeger, Swati Sakhuja, Shakia T. Hardy, Oluwasegun Philip Akinyelure, Joshua D. Bundy, Paul Muntner, Paul Kieran Whelton · 2021 · Journal of Hypertension
  17. Targeting the peptidase PCSK9 to reduce cardiovascular risk: Implications for basic science and upcoming challenges
    Toshiyuki Nishikido, Kausik Kumar Ray · 2019 · British Journal of Pharmacology
  18. Changes in Cardiometabolic Risk Among Older Adults with Obesity: An Ancillary Analysis of a Randomized Controlled Trial Investigating Exercise Plus Weight Maintenance and Exercise Plus Intentional Weight Loss by Caloric Restriction
    Anna Bragg, Kristi M Crowe-White, Amy Cameron Ellis, Matthew B. Studer, Frank Phillips, Steven Samsel, Jason Parton, Julie L. Locher, Jamy D. Ard · 2021 · Journal of the Academy of Nutrition and Dietetics
  19. Prevalence and significance of risk enhancing biomarkers in the United States population at intermediate risk for atherosclerotic disease
    Gloria Lena Vega, Jijia Wang, Scott M. Grundy · 2021 · Journal of clinical lipidology
  20. DNA Methylation of Birthweight–Blood Pressure Genes and Changes of Blood Pressure in Response to Weight-Loss Diets in the POUNDS Lost Trial
    Minghao Kou, Xiang Li, Xiaojian Shao, Elin Grundberg, Xuan Wang, Hao Ma, Yoriko Heianza, José Alfredo Martínez, George A. Bray, Frank M. Sacks et al. · 2023 · Hypertension
  21. Resting heart rate – The forgotten risk factor? Comparison of resting heart rate and hypertension as predictors of all-cause mortality in 692,217 adults in Asia and Europe
    Chi Pang Wen, Chien Hua Chen, Javaid Nauman, Jackson Pui Man Wai, Min‐Kuang Tsai, Jun-Han Lee, Ta-Wei David Chu, Emma Ingeström, Hong Yi Chiou, Chih Cheng Hsu et al. · 2025 · Progress in Cardiovascular Diseases
  22. Cardiovascular disease risk estimates using the new PREVENT Equation: The good, bad, and the ugly
    Pooja V. Selvam, Rahul Sharma, Peter Ganz, Roger Scott Blumenthal, Martha Gulati · 2025 · American Journal of Preventive Cardiology
  23. Selective Use of Coronary Artery Calcium Testing for Shared Decision Making: Guideline Endorsed and Ready for Prime Time
    Rhanderson N. Cardoso, Khurram Nasir, Roger Scott Blumenthal, Michael Joseph Blaha · 2019 · Annals of Internal Medicine
  24. Harnessing the Plasma Proteome to Predict Mortality in Heart Failure Subpopulations
    Jessica Chadwick, Michael Hinterberg, Folkert Wouter Asselbergs, Hannah Biegel, Eric H. Boersma, Thomas P. Cappola, Julio A. Chirinos, Josef Coresh, Peter Ganz, David A. Gordon et al. · 2025 · Circulation Heart Failure
  25. Real‐World Evidence Linking the Predicting Risk of Cardiovascular Disease Events Risk Score and Coronary Artery Calcium
    Aaron J. Rhee, Krutika Pandit, Jeffrey S. Berger, Eduardo Iturrate, Josef Coresh, Sadiya S. Khan, Jung‐Im Shin, Judith S. Hochman, Harmony R. Reynolds, Morgan Erika Grams · 2025 · Journal of the American Heart Association
  26. Higher adherence to (poly)phenol-rich diet is associated with lower CVD risk in the TwinsUK cohort
    Yong Li, Xinyu Yan, Yifan Xu, Robert Pope, Tim D. Spector, Mario Falchi, Claire J. Steves, Jordana T. Bell, Kerrin S. Small, Cristina Menni et al. · 2025 · BMC Medicine
  27. 2018 Cholesterol Guidelines: Key Topics in Primary Prevention
    Donald Clark, Salim S. Virani · 2019 · Current Atherosclerosis Reports
  28. Coronary and Extra-coronary Subclinical Atherosclerosis to Guide Lipid-Lowering Therapy
    Jelani Kayode Grant, Carl E. Orringer · 2023 · Current Atherosclerosis Reports
  29. The Potential Impact of Mammographic Breast Arterial Calcification On Physician Practices in a Primary Care Setting
    Melissa Gennarelli, Andrzej Jedynak, Leanne Forman, Eric Wold, Rebecca B. Newman, Abhay Dhand, Aromma Kapoor, Firas Muhammad Jafri, Suman Pal, Jay Pandav et al. · 2021 · Future Cardiology
  30. A simplified approach to identification of risk status in patients with atherosclerotic cardiovascular disease
    Aparna P. Sajja, Hsin-Fang Li, Kateri J. Spinelli, Amir Ali, Salim S. Virani, Seth Shay Martin, Ty J. Gluckman · 2021 · American Journal of Preventive Cardiology
  31. Isolated diastolic vs. systolic hypertension phenotypes and outcomes: prospective cohort of newly diagnosed individuals with hypertension
    Costas Thomopoulos, Ioannis Andrikou, D. Konstantinidis, Panagιotis Iliakis, Theodoros Kalos, Dimitrios Polyzos, Sotirios Drogkaris, Eirini P. Siafi, Dimitrios M. Tousoulis, George S. Stergiou et al. · 2021 · Journal of Hypertension
  32. Cardiovascular Risk Assessment and Prevention Across the Life Course
    Donald M. Lloyd‐Jones, John T. Wilkins · 2023 · Journal of the American College of Cardiology
  33. Implementing the PREVENT Risk Equation in the 2025 Guideline for the Prevention, Detection, Evaluation, and Management of High Blood Pressure in Adults
    Aletta Elisabeth Schutte, Louise Pilote · 2025 · Hypertension
  34. Risk-enhancing factors and social determinants of health in risk assessment for atherosclerotic cardiovascular disease
    Yiyi Zhang, Jaejin An, Mengying Xia, Hui Cynthia Zhou, Yifei Sun, Joanie Chung, Mengnan Zhou, Soon Kyu Choi, Kerresa L. Morrissette, Paul Muntner et al. · 2024 · PLoS ONE
  35. Risco Cardiovascular e Elegibilidade Para Estatina na Prevenção Primária: Comparação Entre a Diretriz Brasileira e a Diretriz da AHA/ACC
    Fernando Yue Cesena, Viviane A. Valente, Raul Dias Santos, Márcio Sommer Bittencourt · 2020 · Arquivos Brasileiros de Cardiologia
  36. Digital health innovation and artificial intelligence in cardiovascular care: a case-based review
    Jelani Kayode Grant, Aamir Javaid, Richard T. Carrick, Margaret Koester, Ali Asghar Kassamali, Chang H. Kim, Nino Isakadze, Kathérine C. Wu, Michael Joseph Blaha, Seamus Paul Whelton et al. · 2024 · npj Cardiovascular Health
  37. Hypertensive Urgency: An Emergency Department Pipeline to Primary Care Pilot Study
    Antonio Giaimo, Angela Kang, Stephen Joseph Huot · 2020 · American Journal of Hypertension
  38. Hypertension defined by the 2017 ACC/AHA guideline is more accurate than 2018 ESC/ESH for detecting early vascular aging in young adults
    Mariana P. de Souza, Paulo Cesar Lopes, Gabriel Bazo, Paulo Ricardo H. Rocha, Daniela Aparecida Lorencini, Heloisa Bettiol, Marco Antonio Barbieri, Eduardo B. Coelho · 2022 · Medicine
  39. Coronary artery calcium paradox and physical activity
    Gaurav Singh Gulsin, Alastair James Moss · 2021 · Heart
  40. The Hidden and Unchecked Judgement Calls When Using Exacerbation History for Managing COPD
    Mohsen Sadatsafavi, Shawn David Aaron, Andrea S. Gershon, Milo Alan Puhan, Amin Adibi, Don D. Sin · 2021 · Archivos de Bronconeumología
  41. The Evolving Landscape of Cardiovascular Risk Assessment
    Jelani Kayode Grant, Chiadi E. Ndumele, Seth Shay Martin · 2024 · JAMA
  42. Self-rated health and risk of incident cardiovascular events among individuals with hypertension
    Richard Kazibwe, Ahmad Imtiaz Muhammad, Matthew J. Singleton, Joni K. Evans, Parag Anilkumar Chevli, Juliana H. Namutebi, Joseph Kazibwe, Isabella Epiu, Charles Amir German, Elsayed Z. Soliman et al. · 2024 · Journal of Hypertension
  43. Stakeholder-informed positivity thresholds for disease markers and risk scores: a methodological framework and an application in obstructive lung disease
    Mohsen Sadatsafavi, Amir Khakban, Tima Mohammadi, Samir Gupta, Nick J Bansback · 2024 · Journal of Clinical Epidemiology
  44. Development and validation of PRECISE-X model: predicting first severe exacerbation in COPD
    Mohsen Sadatsafavi, Marc Miravitlles, Jennifer Kathleen Quint, Valeria Perugini, Hamid Tavakoli, Joseph Emil Amegadzie, Bernardino Alcázar Navarrete, Respiratory Effectiveness Group (REG)-COPD Working Group · 2025 · Thorax
  45. Implementing an Automated Prediction Model to Improve Prescribing of HIV Preexposure Prophylaxis
    Douglas Krakower, Michael I. Lieberman, Miguel Marino, Jun Hyun Hwang, Kenneth Hugh Mayer, Julia L. Marcus · 2023 · NEJM Catalyst
  46. Evaluating the atherosclerosis cardiovascular disease risk score in patients with brain metastases: Associations with overall survival and high-value care outcomes
    Foad Kazemi, Jiaqi Liu, Megan Parker, Joshua Robinaugh, Ali Karim Ahmed, Jordina Rincón-Torroella, Christopher Mitchell Jackson, Gary L. Gallia, Chetan Bettegowda, JON D. WEINGART et al. · 2024 · Clinical Neurology and Neurosurgery
  47. Diagnostic value of clinical risk scores for predicting normal stress myocardial perfusion imaging in subjects without coronary artery calcium
    Rosario Megna, Carmela Nappi, Valeria Gaudieri, Teresa Mannarino, Roberta Assante, Emilia Zampella, Roberta Green, Valeria Cantoni, Adriana D’Antonio, Parthiban Arumugam et al. · 2020 · Journal of Nuclear Cardiology
  48. Advances in predicting cardiovascular risk: Applying the PREVENT equations
    Deen L. Garba, Alexander C. Razavi, Roger Scott Blumenthal, Neil J. Stone, Tamar S. Polonsky, Sadiya S. Khan, Lili A. Barouch · 2024 · American Journal of Preventive Cardiology
  49. From Calculation to Communication: Using Risk Score Calculators to Inform Clinical Decision Making and Facilitate Patient Engagement
    Hoda Fakhari, Courtney Lynam Scherr, Sydney Moe, Christin Hoell, Maureen E. Smith, Laura J. Rasmussen‐Torvik, Rex L. Chisholm, Elizabeth M. McNally · 2024 · Medical Decision Making
  50. Cardiovascular Disease Risk Screening for Commercial Drivers Examined in Occupational Practice: Implementing Evidence-Based Practice to Champion the Health of Essential Workers
    Annette Barnes · 2023 · Workplace Health & Safety
  51. Modern algorithms for statin therapy
    Andrey V. Susekov · 2023 · Russian Journal of Cardiology
  52. Detection and Management of Heart Disease in Athletes
    David M. Siebert, Jonathan A. Drezner · 2019 · Primary Care Clinics in Office Practice
  53. Improving Access to Guideline-Based Coronary Artery Calcium Testing for Cardiovascular Disease Prevention
    Adam N. Berman, Ron Blankstein · 2019 · JAMA Cardiology
  54. Incorporating Coronary Calcium Scoring Into Risk Assessment For Primary Prevention
    Donald M. Lloyd‐Jones · 2021 · JACC. Cardiovascular imaging
  55. Interleukin-6 is associated with high-risk plaque on coronary computed tomography angiography in asymptomatic women
    Nishant Vatsa, Raymundo Alain Quintana, Phillipp Knebel Doeberitz, Carlotta Onnis, Sonika Vatsa, Noah A. Newman, Tanveer Kauser, Alireza Rahbar, Daniel A. Gold, Vardhmaan Jain et al. · 2025 · American Journal of Preventive Cardiology
  56. Comparison of Framingham risk score and pooled cohort equations for the prediction of coronary atherosclerosis in patients who meet the target LDL-C level of Korean dyslipidemia guideline
    Su Bin Kim, Hae Won Jung · 2022 · Medicine
  57. Evaluating Plasma Galectin-3 Levels in Patients With an Increased Risk of Atherosclerotic Cardiovascular Disease Who Underwent Coronary Artery Revascularization
    Fadia Mayyas, Khalid S Ibrahim · 2023 · The American Journal of Cardiology
  58. Effect of low-volume exercise on hepatic steatosis in adults with obesity plus normal glucose, prediabetes or type 2 diabetes: a randomised controlled trial
    Callum John Baker, SAMANTHA L. HOCKING, Xiaoyu Wang, James A. Gerofi, Stephen Colagiuri, Angelo Sabag, Lynda M. Molyneaux, Yu Xu, Mian Li, Yufang Bi et al. · 2024 · BMJ Open Sport & Exercise Medicine
  59. Renal arteriosclerosis in kidney biopsies associated with higher 10-year atherosclerotic cardiovascular disease in lupus nephritis
    Shivani Garg, Brad C. Astor, Sung Sam Lim, Amish N. Raval, Weixiong Zhong, Sarah E. Panzer, Arezou Khosroshahi, Brad H. Rovin, Christie Michels Bartels · 2024 · Rheumatology
  60. Revealing the limitations of 10-year MACE observations: 20-year observed total cardiovascular burden in the EPIC-Norfolk study
    T J Van Trier, Marjolein Snaterse, Jannick A N Dorresteijn, Manon van den Bogaart, Wilma J.M. Scholte op Reimer, Frank L.J. Visseren, Ron J.G. Peters, Harald Thune Jorstad, S. Matthijs Boekholdt · 2025 · Open Heart
  61. Sex Differences in Effectiveness of Semaglutide in Patients With Peripheral Artery Disease
    Subodh Verma, Andrei‐Mircea Catarig, Kim Christian Houlind, Bernhard H. Ludvik, Joakim Nordanstig, Neda Rasouli, Harald Sourij, Sebastian Thomas, Sidse Kjærhus Nørgaard, Marc P. Bonaca · 2025 · Journal of the American College of Cardiology
  62. Preulcerous Risk Situation in Diabetic Foot Syndrome: Proposal for a Simple Ulcer Prevention Score
    Stephan Kreß, Helmut Anderten, Anja Borck, Guido Freckmann, Lutz Heinemann, Ulrike Holzmüller, Bernd Kulzer, Alexandra Portele, Oliver Schnell, Helga Varlemann et al. · 2020 · Journal of Diabetes Science and Technology
  63. Developing a synthetic control group using electronic health records: Application to a single-arm lifestyle intervention study
    Yi‐An Ko, Zhenchao Chen, Chang Liu, Yingtian Hu, Arshed Ali Quyyumi, Lance Allyn Waller, Melinda Kay Higgins, Thomas R. Ziegler, Kenneth L. Brigham, Greg S. Martin · 2021 · Preventive Medicine Reports
  64. Implications of the heterogeneity between guideline recommendations for the use of low dose aspirin in primary prevention of cardiovascular disease
    Xiaoying Li, Li Li, Sang Hoon Na, Francesca Santilli, Zhongwei Shi, Michael Joseph Blaha · 2022 · American Journal of Preventive Cardiology
  65. Percentiles of predicted 10-year cardiovascular disease risk by sex and age in Brazil and their association with estimated risk of long-term atherosclerotic events
    Fernando Yue Cesena, Giuliano Generoso, Itamar S Santos, Bruce Bartholow Duncan, Antônio Luiz Pinho Ribeiro, Luísa Campos Caldeira Brant, José Geraldo Mill, Alexandre C. Pereira, Márcio Sommer Bittencourt, Raul Dias Santos et al. · 2023 · Preventive Medicine
  66. The Evolving View of Coronary Artery Calcium: A Personalized Shared Decision-Making Tool in Primary Prevention
    Omar Dildar a Dzaye, Cara Reiter–Brennan, Albert Danso Osei, Olusola Ayodeji Orimoloye, S.M. Iftekhar Uddin, Mohammadhassan Mirbolouk, Michael Joseph Blaha · 2019 · Cardiology Research and Practice
  67. Geographic and Sociodemographic Disparities in Cardiovascular Risk in Burkina Faso: Findings from a Nationwide Cross-Sectional Survey
    Kadari Cissé, Sékou Samadoulougou, Mady Ouédraogo, Bruno Bonnechère, Jean‐Marie Degryse, Séni Kouanda, Fati Kirakoya‐Samadoulougou · 2021 · Risk Management and Healthcare Policy
  68. Lifetime risk of cardiovascular disease stratified by traditional risk factors: Findings from the cohort of Tehran lipid and glucose study
    Azra Ramezankhani, Fereidoun Azizi, Farzad Hadaegh · 2023 · Hellenic Journal of Cardiology
  69. Rationale and design for Healthy Hearts in Manufacturing (HHM): A pragmatic single-arm hybrid effectiveness-implementation study for hypertension management and tobacco cessation
    Hongzhou Jiang, Yao Tian, Jennifer E. Bannon, Amy E. Krefman, Lawrence C. An, Dustin D. French, Claude R. Maechling, Jane Louise Holl, Richard Chagnon, Theresa L. Walunas et al. · 2025 · Contemporary Clinical Trials Communications
  70. Plasma neutrophil gelatinase-associated lipocalin level as a predictor of atherosclerotic cardiovascular disease risk in patients undergoing catheterization
    Fadia Mayyas · 2025 · Microvascular Research
  71. The AIR·MS data platform for artificial intelligence in healthcare
    Pablo Guerrero, Morten Ernebjerg, Thomas Holst, David Weese, Herve DiBello, Susanne Ibing, Linea Schmidt, Ryan C. Ungaro, Bernhard Y. Renard, Christoph Lippert et al. · 2025 · JAMIA Open
  72. Diagnostic cardiac CT for the improvement of cardiovascular event prediction
    Raimund M. Erbel, Nils Lehmann, Sara Helena Schramm, Börge Schmidt, Anika Hüsing, Bernd Kowall, Dirk Matthias Hermann, Janine Gronewold, Axel Schmermund, Stefan Möhlenkamp et al. · 2023 · Deutsches Ärzteblatt international
  73. Confirmation of Statin and Fibrate Use from Small-Volume Archived Plasma Samples by High-Throughput LC-MS/MS Method
    Jennifer D Kusovschi, Anna Ivanova, Michael S. Gardner, Robert W. McGarrah, William E. Kraus, Zsuzsanna Kuklenyik, James L. Pirkle, John Robert Barr · 2023 · International Journal of Molecular Sciences
  74. Determinants of Cardio-Ankle Vascular Index and Heart-Thigh β Index in the MESA
    Hamed Tavolinejad, Kevin E. Boczar, Bart Spronck, Hannah Maynard, Alain Gerald Bertoni, Sanjiv Jayendra Shah, Julio A. Chirinos · 2025 · Hypertension
  75. Cardiovascular risks in men with prostate cancer: a pragmatic, clinician-oriented review of risk stratification and management strategies
    Aditya H. Bhave, Harikrishnan Hyma Kunhiraman, Tarek Nahle, Ritu Reddy, Omar Mohamed Makram, Priyanshu Nain, Viraj R Shah, Umang Swami, Sagar Anil Patel, Ashanda Rosetta Patrice Esdaille et al. · 2025 · Prostate Cancer and Prostatic Diseases
  76. The role of sex and systemic inflammation in the development of cardiovascular disease in osteoarthritis: A population-based cohort study using the CLSA
    Anthony V. Perruccio, Caitlin Kral, Calvin Yip, Lihi Eder, J. Denise Power, Mayilée Cañizares, Jessica M. Wilfong, George A. Heckman, Elizabeth M. Badley · 2025 · Seminars in Arthritis and Rheumatism
  77. Carotid Artery Imaging Is More Strongly Associated With the 10-Year Atherosclerotic Cardiovascular Disease Score Than Coronary Artery Imaging
    Ying Li, Guangming Zhu, Victoria Y. Ding, Bin Jiang, Derek B. Boothroyd, Fátima Rodríguez, Dominik Fleischmann, Manisha Desai, David Saloner, Luca Saba et al. · 2019 · Journal of Computer Assisted Tomography
  78. Cardiovascular Risk Calculators and their Applicability to South Asians
    Manish Bansal, Shraddha Ranjan, Ravi Ratan Kasliwal · 2020 · Current Diabetes Reviews
  79. Implications of Premature Coronary Artery Calcification in Primary and Secondary Prevention of Atherosclerotic Cardiovascular Disease
    Sumeet A. Khetarpal, Michael C. Honigberg, Pradeep Natarajan · 2021 · JAMA Cardiology
  80. Contextualizing National Policies Regulating Access to Low‐Dose Aspirin in America and Europe Using the Full Report of a Transatlantic Patient Survey of Aspirin in Preventive Cardiology
    Alan P. Jacobsen, Zi Lun Lim, Blair Chang, Kaleb D. Lambeth, Thomas M. Das, Colin Gorry, Michael McCague, Faisal Sharif, Darren Mylotte, William C. Wijns et al. · 2022 · Journal of the American Heart Association
  81. Ten‐Year Risk Equations for Incident Heart Failure in Established Atherosclerotic Cardiovascular Disease Populations
    Luke P. Dawson, Melinda Jane Carrington, Tilahun Haregu, Shane Nanayakkara, Garry Jennings, Anthony Michael Dart, Dion A. Stub, Michael Inouye, David M. Kaye · 2024 · Journal of the American Heart Association
  82. Perspectives on the management of hypertension in Japan
    Tatsuya Maruhashi, Yasuki Kihara, Yukihito Higashi · 2020 · Expert Opinion on Pharmacotherapy
  83. Coronary Artery Calcium and Prevention Guidelines
    Harvey S. Hecht · 2019 · JACC. Cardiovascular imaging
  84. Inherited risk of coronary artery disease: redefining care with imaging and genetics
    Nick S.R. Lan, Girish Dwivedi, Graham S. Hillis, Derek P. Chew, Bu Beng Yeap, Gemma A. Figtree, Amit V. Khera, Gerald Francis Watts, Abdul Rahman Ihdayhid · 2026 · Nature Reviews Cardiology
  85. Retinal Thinning in People With Well-Controlled HIV Infection
    Katrina Geannopoulos, Cynthia C. McMahan, Ramiro S. Maldonado, Akshar B. Abbott, Jared E. Knickelbein, Elvira Agrón, Tianxia Wu, Joseph Snow, Govind Nair, Elizabeth F. Horne et al. · 2022 · JAIDS Journal of Acquired Immune Deficiency Syndromes
  86. Impaired response of memory Treg to high density lipoproteins is associated with intermediate/high cardiovascular disease risk in persons with HIV
    Laura Atehortúa, Mirza Baig, Jamie C Morris, Sarah Trentman, William Sean Davidson, Carl J. Fichtenbaum, Claire Anne Chougnet · 2023 · Frontiers in Immunology
  87. The Future of Cognitive Screening in Neurodegenerative Diseases
    Laura Glass Umfleet, Robert M. Bilder, David W. Loring, April D. Thames, Benjamin M. Hampstead, Russell M. Bauer, Daniel L. Drane, Lucia Cavanagh · 2023 · Journal of Alzheimer s Disease
  88. Perspectives of Healthcare Professionals on Clinician–Patient Communication of Cardiovascular Disease Risk
    Mark Campbell, John William McEvoy, Gavin G. Calpin, Fiona Concannon, Sam Redfern · 2024 · Journal of Patient Experience
  89. Identification of protein targets for dyslipidaemia and cardiovascular diseases among people with South Asian ancestry: a mendelian randomisation study
    Siwei Wu, Devendra Meena, Alexander Smith, Jingxian Huang, Georg Otto, Yi-Hsuan Ko, James Yarmolinsky, Dipender Gill, Anand K. Rohatgi, Abbas Dehghan et al. · 2025 · The Lancet Regional Health - Southeast Asia
  90. Coronary artery calcium scoring in patients with statin associated muscle symptoms: Prescribing statins for those most likely to benefit
    Carl E. Orringer, Michael Joseph Blaha, Neil J. Stone · 2021 · Journal of clinical lipidology
  91. Effects of aromatase inhibitor therapy on visceral adipose tissue area and cardiometabolic health in postmenopausal women with early and locally advanced breast cancer
    Yee-Ming Melody Cheung, Rudolf Hoermann, Karen Van, Damian Wu, Jenny Healy, Michael Chao, Shane C. White, Belinda Jane Yeo, Jeffrey D. Zajac, Mathis Grossmann · 2022 · Clinical Endocrinology
  92. Estimated Cardiovascular Risk and Guideline-Concordant Primary Prevention With Statins: Retrospective Cross-Sectional Analyses of US Ambulatory Visits Using Competing Algorithms
    Kathleen A. Fairman, David Romanet, Nicole K. Early, Kellie J. Goodlet · 2019 · Journal of Cardiovascular Pharmacology and Therapeutics
  93. Association between Three Variants in the PRKAA2 gene, rs2796498, rs9803799, and rs2746342, with 10-year ASCVD Risk on Newly Diagnosed T2DM in Yogyakarta, Indonesia
    Dita Maria Virginia, Mae Sri Hartati Wahyuningsih, Dwi Aris Agung Nugrahaningsih · 2021 · Open Access Macedonian Journal of Medical Sciences
  94. Safety incidents and obstructive sleep apnoea in railway workers
    M Abeyaratne, Armand Casolin, Georgina M. Luscombe · 2023 · Occupational Medicine
  95. Effects of aromatase inhibitor therapy on adiposity and cardiometabolic health in postmenopausal women: a controlled cohort extension study
    Yee-Ming Melody Cheung, Rudolf Hoermann, Karen Van, Damian Wu, Jenny Healy, Bella Halim, Manjri Raval, Maria McGill, Ali H. Al-Fiadh, Michael Chao et al. · 2023 · Endocrine Connections
  96. Assessment of Lifetime Risk for Cardiovascular Disease: Time to Move Forward
    Evangelia G. Sigala, Demosthenes B. Panagiotakos · 2024 · Current Cardiology Reviews
  97. When Does Primary Prevention Encroach on Secondary Prevention?
    Matthew R. Deshotels, Prasanti Alekhya Kotta, Juan Simon Rico Mesa, Olamide Oyenubi, Vijay Nambi · 2024 · Current Atherosclerosis Reports
  98. Applicability and Risk Stratification of QRISK®, Framingham Risk Score, Systematic Coronary Risk Evaluation (SCORE), and American College of Cardiology/American Heart Association (ACC/AHA) Risk Assessment Tools Among Patients in Taif, Saudi Arabia
    Suha Alnefaie, Ameerah Saleh Bajaber, Ahmad Alzahrani, Rakan Alotaibi, Amjad J Alotaibi · 2025 · Cureus
  99. Impact of multifactorial interventions with medication and lifestyle optimization on patients with type 2 diabetes: A randomised controlled trial
    Marwan El-Deyarbi, Luai Awad Ahmed, Jeffrey King, Zelal S. Adi, Ahmed Al Juboori, Nirmin A. Mansour, Huda Al Nuaimi, Rami Beiram, Salahdein Aburuz · 2025 · PLoS ONE
  100. Prognostic Value of the American Heart Association PREVENT Cardiovascular Disease Risk Equations in Cancer Survivorship: A NHANES Population‐Based Study (2009–2018)
    Mustafa Hussein Ajlan Al-Jarshawi, Ofer M. Kobo, Dennis T. Ko, Harindra Channa Wijeysundera, M. Golam Azam, Victoria Silverwood, Ram Chandra Bajpai, Rodrigo Bagur, Mamas A. Mamas · 2025 · Journal of the American Heart Association